BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16044108)

  • 41. Short courses of antibiotic in acute otitis media and sinusitis infections.
    Pichicero M
    J Int Med Res; 2000; 28 Suppl 1():25A-36A. PubMed ID: 11092227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of amoxycillin/clavulanic acid in experimental Bacteroides fragilis/Escherichia coli mixed infections.
    Beale AS; Gisby J; Sutherland R
    J Antimicrob Chemother; 1988 Apr; 21(4):451-9. PubMed ID: 3288604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review.
    Gentry LO
    Clin Infect Dis; 1992 Jan; 14(1):285-97. PubMed ID: 1571443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
    Ball P
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):851-6. PubMed ID: 7889959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dosing of amoxicillin/clavulanate given every 12 hours is as effective as dosing every 8 hours for treatment of lower respiratory tract infection. Lower Respiratory Tract Infection Collaborative Study Group.
    Calver AD; Walsh NS; Quinn PF; Baran C; Lonergan V; Singh KP; Orzolek WS
    Clin Infect Dis; 1997 Apr; 24(4):570-4. PubMed ID: 9145729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roxithromycin versus amoxicillin-clavulanic acid in the treatment of respiratory tract infections.
    Lousbergh D; Jochems G; Everaert L; Puttemans M
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):91S-95S. PubMed ID: 1617931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The variability and appropriateness of the antibiotic prescription of acute otitis media in childhood. The Spanish Study Group for Antibiotic Treatments.
    Solís G; Ochoa C; Pérez Méndez C
    Int J Pediatr Otorhinolaryngol; 2000 Dec; 56(3):175-84. PubMed ID: 11137591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does the use of amoxicillin/amoxicillin-clavulanic acid in third molar surgery reduce the risk of postoperative infection? A systematic review with meta-analysis.
    Menon RK; Gopinath D; Li KY; Leung YY; Botelho MG
    Int J Oral Maxillofac Surg; 2019 Feb; 48(2):263-273. PubMed ID: 30145064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
    Léophonte P; File T; Feldman C
    Respir Med; 2004 Aug; 98(8):708-20. PubMed ID: 15303634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-Dose vs Standard-Dose Amoxicillin Plus Clavulanate for Adults With Acute Sinusitis: A Randomized Clinical Trial.
    Gregory J; Huynh B; Tayler B; Korgaonkar-Cherala C; Garrison G; Ata A; Sorum P
    JAMA Netw Open; 2021 Mar; 4(3):e212713. PubMed ID: 33755168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice.
    Bucher HC; Tschudi P; Young J; Périat P; Welge-Lüussen A; Züst H; Schindler C;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1793-8. PubMed ID: 12912714
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Amoxicillin/clavulanic acid in therapy of bacterial infections of the diabetic foot. Results of an observational study].
    Gerards V; Schiewe U; Gerards HH; Machka K; Höbel W; Meister W
    MMW Fortschr Med; 2000 Jan; 142(3 Suppl):187-94. PubMed ID: 10783611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ambulatory treatment with cefuroxime-axetil of infectious bronchitis in patients sixty years of age or older: comparative study of the combination of amoxicillin and clavulanic acid].
    Hugonot R; Hugonot L; Pappo M; Chiche D
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):533-7. PubMed ID: 2200995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes.
    Dohar J; Giles W; Roland P; Bikhazi N; Carroll S; Moe R; Reese B; Dupre S; Wall M; Stroman D; McLean C; Crenshaw K
    Pediatrics; 2006 Sep; 118(3):e561-9. PubMed ID: 16880248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
    Pelletier LL
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S238-43; discussion S244-5. PubMed ID: 1617044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amoxicillin/clavulanic acid is ineffective at preventing otitis media in children with presumed viral upper respiratory infection: a randomized, double-blind equivalence, placebo-controlled trial.
    Autret-Leca E; Giraudeau B; Ployet MJ; Jonville-Béra AP
    Br J Clin Pharmacol; 2002 Dec; 54(6):652-6. PubMed ID: 12492614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions.
    Torres MJ; Ariza A; Mayorga C; Doña I; Blanca-Lopez N; Rondon C; Blanca M
    J Allergy Clin Immunol; 2010 Feb; 125(2):502-505.e2. PubMed ID: 20159266
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of the efficacy of amoxicillin-clavulanic acid, cefovecin, and doxycycline in the treatment of upper respiratory tract disease in cats housed in an animal shelter.
    Litster AL; Wu CC; Constable PD
    J Am Vet Med Assoc; 2012 Jul; 241(2):218-26. PubMed ID: 22765368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimating the impact of cefuroxime versus cefazolin and amoxicillin/clavulanate use on future collateral resistance: a retrospective comparison.
    Chowers M; Zehavi T; Gottesman BS; Baraz A; Nevo D; Obolski U
    J Antimicrob Chemother; 2022 Jun; 77(7):1992-1995. PubMed ID: 35425954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.